The average level of urinary exosomal CA9 was not only significantly increased in BC patients compared to controls, but Wen et al. also suggest that the detection of exo-CA9 mRNA might have a sufficient sensitivity and specificity to be used as a marker for the diagnosis of BC [102]. This evidence concerns the gene CA9 and breast cancer.